ArticleAlcohol (Fayetteville, N.Y.)2026
The analgesic effect of neuropeptide S (NPS) in alcohol-dependent male and female rats.
Article in Alcohol (Fayetteville, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
introductionAlcohol dependence (AD) includes tolerance to alcohol's analgesic effects and increased pain sensitivity during withdrawal (i.e., hyperalgesia). Further, the reciprocal relationship between alcohol use and pain sensitivity is hypothesized to contribute to the maintenance of AD through negative reinforcement (i.e., self-medication). The neuropeptide S (NPS) system, known to regulate stress, arousal, and pain pathways, may offer a therapeutic target to ameliorate AD-induced hyperalgesia. Given previous reports on the antinociceptive properties of NPS, we hypothesized that central administration of NPS could attenuate the heightened pain sensitivity observed in AD rats.
methodsMale (n = 11) and female (n = 7) Wistar rats were surgically implanted with an intracerebroventricular (ICV) cannula and assigned to either the AD or alcohol-naïve control group, matched in terms of their baseline thermal nociceptive thresholds. Pain sensitivity was tracked weekly using thermal (Hargreaves) and mechanical (robotic Von Frey, also known as the dynamic plantar aesthesiometer) assays to establish AD-induced hyperalgesia. After stable hyperalgesia emerged, rats received ICV NPS administrations (0, 0.1, or 1 nmol in 5 μL saline) 5 min prior to pain testing (Experiment 1: Hargreaves; Experiment 2: robotic Von Frey). In a follow-up experiment, three Von Frey methods (electronic, robotic, and manual) were compared to assess their efficacy in detecting AD-induced mechanical hyperalgesia.
resultsAD male and female rats developed significant hyperalgesia across both pain modalities. Central administration of NPS produced robust analgesia in a dose-dependent manner in both AD and alcohol-naïve control rats. No sex differences were observed in baseline nociception, AD-induced hyperalgesia, or NPS-induced analgesia. All three mechanical assays reliably detected AD-induced mechanical hyperalgesia, and the importance of adequate habituation procedures is discussed.
conclusionThese findings indicate that NPS exerts a robust analgesic effect in male and female rats. This effect appears independent of ethanol-exposure history but produces sufficient analgesia to alleviate pain sensitivity in hyperalgesic AD rats to/beyond the level of sensitivity in vehicle treated, alcohol-naïve controls. The NPS system may therefore represent a promising, non-addictive target for treating pain-related symptoms in alcohol dependence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.